US2006159750A1PendingUtilityA1

Pharmaceutical dosage form bearing pregnancy-friendly indicia

61
Assignee: DUCHESNAY INCPriority: Jul 5, 2002Filed: Mar 20, 2006Published: Jul 20, 2006
Est. expiryJul 5, 2022(expired)· nominal 20-yr term from priority
Inventors:Éric GervaisGordana AtanackovicRaymond T. Hebert
A61K 45/06A61K 31/44A61K 31/4402A61K 31/4415A61K 9/2072
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.

Claims

exact text as granted — not AI-modified
1 - 9 . (canceled)  
   
   
       10 . A method of diminishing the perception of teratogenic risk among pregnant women taking a pharmaceutical dosage form containing at least one active ingredient, said method comprising providing pregnant women with the pharmaceutical dosage form bearing pregnancy-friendly indicia so as to graphically confirm the non-teratogenic aspect of the pharmaceutical dosage form.  
   
   
       11 . The method of  claim 10  wherein said pregnancy-friendly indicia is in the shape of a graphical illustration of a pregnant woman applied to the dosage form itself or to its packaging.  
   
   
       12 . The method of  claim 10  wherein the at least one active ingredient comprises at least one vitamin.  
   
   
       13 . The method of  claim 10  wherein the at least one active ingredient comprises the active ingredients pyridoxine HCl and doxylamine succinate.  
   
   
       14 . The method of  claim 10  wherein the pharmaceutical dosage form is an oral dosage form.  
   
   
       15 . A method of improving patient compliance of pregnant women with medically recommended dosage regimen of at least one active ingredient, said method comprising providing pregnant women with a pharmaceutical dosage form bearing pregnancy-friendly indicia so as to graphically confirm the non-teratogenic aspect of the pharmaceutical dosage form and thereby achieve greater patient compliance with the medically recommended dosage regimen.  
   
   
       16 . The method of  claim 15  wherein said pregnancy-friendly indicia is in the shape of a graphical illustration of a pregnant woman applied to the dosage form itself or to its packaging.  
   
   
       17 . The method of  claim 15  wherein the at least one active ingredient comprises at least one vitamin.  
   
   
       18 . The method of  claim 15  wherein the at least one active ingredient comprises the active ingredients pyridoxine HCl and doxylamine succinate.  
   
   
       19 . The method of  claim 15  wherein the pharmaceutical dosage form is an oral dosage form.  
   
   
       20 . A method of improving patient compliance of pregnant women with medically recommended dosage regimen of at least one active ingredient and consequently and simultaneously improving the therapeutic effectiveness of said active ingredient(s), said method comprising providing pregnant women with a pharmaceutical dosage form bearing pregnancy-friendly indicia to graphically confirm the non-teratogenic aspect of said dosage form so as to elicit better patient compliance with the medically recommended dosage regimen.  
   
   
       21 . The method of  claim 20  wherein said pregnancy-friendly indicia is in the shape of a graphical illustration of a pregnant woman applied to the dosage form itself or to its packaging.  
   
   
       22 . The method of  claim 20  wherein the at least one active ingredient comprises at least one vitamin.  
   
   
       23 . The method of  claim 20  wherein the at least one active ingredient comprises the active ingredients pyridoxine HCl and doxylamine succinate.  
   
   
       24 . The method of  claim 20  wherein the pharmaceutical dosage form is an oral dosage form.  
   
   
       25 . A method of diminishing the incidence of erroneous ingestion by pregnant women of therapeutic agents not prescribed to said pregnant women, said method comprising providing pregnant women with a pharmaceutical dosage form comprising at least one active ingredient prescribed to said pregnant women, said dosage form bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.  
   
   
       26 . The method of  claim 25  wherein said pregnancy-friendly indicia is in the shape of a graphical illustration of a pregnant woman applied to the dosage form itself or to its packaging.  
   
   
       27 . The method of  claim 25  wherein the at least one active ingredient comprises at least one vitamin.  
   
   
       28 . The method of  claim 25  wherein the at least one active ingredient comprises the active ingredients pyridoxine HCl and doxylamine succinate.  
   
   
       29 . The method of  claim 25  wherein the dosage form is an oral dosage form.  
   
   
       30 . A method of diminishing the incidence of erroneous dispensing of pharmaceutical dosage forms not intended for pregnant women, said method comprising providing a pharmaceutical dosage form, intended for use by pregnant women, comprising at least one active ingredient and bearing pregnancy-friendly indicia apt to graphically distinguish dosage forms intended to be used during pregnancy from others.  
   
   
       31 . The method of  claim 30  wherein said pregnancy-friendly indicia is in the shape of a graphical illustration of a pregnant woman applied to the dosage form itself or to its packaging.  
   
   
       32 . The method of  claim 30  wherein the at least one active ingredient comprises at least one vitamin.  
   
   
       33 . The method of  claim 30  wherein the at least one active ingredient comprises the active ingredients pyridoxine HCl and doxylamine succinate.  
   
   
       34 . The method of  claim 30  wherein the dosage form is an oral dosage form.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.